1926 related articles for article (PubMed ID: 35405084)
1. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
2. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
COVID-19 Forecasting Team
Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
[TBL] [Abstract][Full Text] [Related]
3. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
COVID-19 Excess Mortality Collaborators
Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
[TBL] [Abstract][Full Text] [Related]
4. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Demographics Collaborators
Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
[TBL] [Abstract][Full Text] [Related]
5. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
COVID-19 National Preparedness Collaborators
Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
[TBL] [Abstract][Full Text] [Related]
6. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Causes of Death Collaborators
Lancet; 2024 May; 403(10440):2100-2132. PubMed ID: 38582094
[TBL] [Abstract][Full Text] [Related]
7. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Fertility and Forecasting Collaborators
Lancet; 2024 May; 403(10440):2057-2099. PubMed ID: 38521087
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.
Eales O; Haw D; Wang H; Atchison C; Ashby D; Cooke GS; Barclay W; Ward H; Darzi A; Donnelly CA; Chadeau-Hyam M; Elliott P; Riley S
PLoS Biol; 2023 May; 21(5):e3002118. PubMed ID: 37228015
[TBL] [Abstract][Full Text] [Related]
9. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Population and Fertility Collaborators
Lancet; 2018 Nov; 392(10159):1995-2051. PubMed ID: 30496106
[TBL] [Abstract][Full Text] [Related]
10. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
[TBL] [Abstract][Full Text] [Related]
11. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
COVID-19 Mental Disorders Collaborators
Lancet; 2021 Nov; 398(10312):1700-1712. PubMed ID: 34634250
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.
Skowronski DM; Kaweski SE; Irvine MA; Chuang ESY; Kim S; Sabaiduc S; Reyes RC; Henry B; Sekirov I; Smolina K
CMAJ; 2023 Oct; 195(42):E1427-E1439. PubMed ID: 37903524
[TBL] [Abstract][Full Text] [Related]
13. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections.
Russell TW; Golding N; Hellewell J; Abbott S; Wright L; Pearson CAB; van Zandvoort K; Jarvis CI; Gibbs H; Liu Y; Eggo RM; Edmunds WJ; Kucharski AJ;
BMC Med; 2020 Oct; 18(1):332. PubMed ID: 33087179
[TBL] [Abstract][Full Text] [Related]
14. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
[TBL] [Abstract][Full Text] [Related]
15. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators
Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
[TBL] [Abstract][Full Text] [Related]
16. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns.
Cabore JW; Karamagi HC; Kipruto HK; Mungatu JK; Asamani JA; Droti B; Titi-Ofei R; Seydi ABW; Kidane SN; Balde T; Gueye AS; Makubalo L; Moeti MR
Lancet Glob Health; 2022 Aug; 10(8):e1099-e1114. PubMed ID: 35659911
[TBL] [Abstract][Full Text] [Related]
18. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
Duong S; Burtniak J; Gretchen A; Mai A; Klassen P; Wei Y; Loeppky C; Shaw SY; Bullard J; Van Caeseele P; Stein DR
BMC Public Health; 2023 Dec; 23(1):2420. PubMed ID: 38053033
[TBL] [Abstract][Full Text] [Related]
19. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
Angulo FJ; Finelli L; Swerdlow DL
JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
[TBL] [Abstract][Full Text] [Related]
20. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
